Pharma Focus Asia

Clean Cells Invests US$14.7 (€13) million to Open New Biopharmaceutical Production Site

Introduction:

Clean Cells with an investment of US$14.7 million (€13 million) plans to open new production site located in Montaigu-Vendée.

Features:

The new production site laid with an area covering 5,300m2 and significantly increases its production capacity of cell banks for vaccines, therapeutic antibodies and gene therapies.

The facility will be dedicated for biopharmaceuticals quality control services and production of cell banks for innovative drugs.

The construction of the production site started in July 2021 and expected to complete in September 2022.

The new biopharmaceutical production site is expected to create 80 new jobs including engineers, technicians as well as roles in scientific, logistical, administrative and sales support.

Specifications:

NameClean Cells
TypeNew Construction
BudgetUS$14.7 (Euro 13) million
YearSeptember 2022

 

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference